Show simple item record

The genomic landscape of plasma cells in systemic light chain amyloidosis.

dc.contributor.authorBoyle, EM
dc.contributor.authorAshby, C
dc.contributor.authorWardell, CP
dc.contributor.authorRowczenio, D
dc.contributor.authorSachchithanantham, S
dc.contributor.authorWang, Y
dc.contributor.authorJohnson, SK
dc.contributor.authorBauer, MA
dc.contributor.authorWeinhold, N
dc.contributor.authorKaiser, MF
dc.contributor.authorJohnson, DC
dc.contributor.authorJones, JR
dc.contributor.authorPawlyn, C
dc.contributor.authorProszek, P
dc.contributor.authorSchinke, C
dc.contributor.authorFacon, T
dc.contributor.authorDumontet, C
dc.contributor.authorDavies, FE
dc.contributor.authorMorgan, GJ
dc.contributor.authorWalker, BA
dc.contributor.authorWechalekar, AD
dc.date.accessioned2018-12-04T12:49:05Z
dc.date.issued2018-12-27
dc.identifier.citationBlood, 2018, 132 (26), pp. 2775 - 2777
dc.identifier.issn0006-4971
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/2966
dc.identifier.eissn1528-0020
dc.identifier.doi10.1182/blood-2018-08-872226
dc.formatPrint-Electronic
dc.format.extent2775 - 2777
dc.languageeng
dc.language.isoeng
dc.publisherAMER SOC HEMATOLOGY
dc.rights.urihttps://www.rioxx.net/licenses/under-embargo-all-rights-reserved
dc.subjectPlasma Cells
dc.subjectHumans
dc.subjectMutation
dc.subjectFemale
dc.subjectMale
dc.subjectImmunoglobulin Light-chain Amyloidosis
dc.titleThe genomic landscape of plasma cells in systemic light chain amyloidosis.
dc.typeJournal Article
dcterms.dateAccepted2018-11-06
rioxxterms.versionofrecord10.1182/blood-2018-08-872226
rioxxterms.licenseref.urihttps://www.rioxx.net/licenses/under-embargo-all-rights-reserved
rioxxterms.licenseref.startdate2018-12
rioxxterms.typeJournal Article/Review
dc.relation.isPartOfBlood
pubs.issue26
pubs.notes12 months
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Therapeutics
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Therapeutics/Myeloma Biology and Therapeutics
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Molecular Pathology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Molecular Pathology/Myeloma Group
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Therapeutics
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Therapeutics/Myeloma Biology and Therapeutics
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Molecular Pathology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Molecular Pathology/Myeloma Group
pubs.publication-statusPublished
pubs.volume132
pubs.embargo.terms12 months
icr.researchteamMyeloma Biology and Therapeutics
icr.researchteamMyeloma Group
dc.contributor.icrauthorKaiser, Martin
dc.contributor.icrauthorPawlyn, Charlotte


Files in this item

Thumbnail
Name:
blood-2018-08-872226.full.pdf
Size:
110.4Kb
Format:
PDF
Description:
Accepted version
View/Open

This item appears in the following collection(s)

Show simple item record